- Project led by Sheffield Teaching Hospitals NHS Foundation Trust in partnership with Sheffield School of Health and Related Research.
- Focused on haemotological cancer care.
- Aimed to develop ambulatory care treatment pathways for blood cancer patients to reduce length of inpatient stay, minimise delays in treatment delivery and enhance the patient experience.
- Used Clinical Microsystems as a service improvement tool to design new treatment pathways and to engage staff and patients in the process.
The Sheffield Teaching Hospitals team developed ambulatory care treatment pathways for blood cancer patients. Ambulatory care involves delivering care on a day case basis or at home. The aims of the project were to:
- reduce length of inpatient stay
- minimise delays in treatment delivery
- increase bed capacity
- enhance the patient experience.
The team used Clinical Microsystems as a service improvement tool to design the treatment pathways and to engage staff and patients in the process. They developed a range of resources and services including:
- new protocols and guidelines
- a patient and carer education programme
- patient information booklets
- a patient alert card
- ambulatory care flats and hotel services
- extended opening hours for the day ward including on weekends.
Who was involved
The Clinical Microsystems team involved doctors, nurses, patients, managers and hotel services, along with a health economist and a pharmacist. The economic impact of the project was led by Sheffield School of Health and Related Research.
The team treated 13 blood cancer patients using ambulatory care pathways between April 2011 and February 2012. All patients treated gave positive feedback.
Ambulatory care significantly reduced the median inpatient length of stay for:
- acute myeloid leukaemia patients receiving consolidation chemotherapy - 7 days compared to 25 days for standard inpatient treatment
- lymphoma patients receiving high dose therapy with stem cell support - 9.5 days compared to 21 days.
Computer simulation modelling predicted that ambulatory care could enable the unit to perform an additional 6-10 bone marrow transplants each year and reduce yearly treatment costs by 7-11%.
Successes and lessons from the first two rounds of the Health Foundation’s Shine programme: annual...
You might also like...
This webinar expands upon the findings of our recent report 'Building healthier communities: the...
A new £2.1m programme for partnerships developing collaborative communities where people, families,...
Aiming to save lives and secure greater independence for hip fracture patients.
Health Foundation @HealthFdn
Loneliness is a concern partly because it is also associated with poor health outcomes. But understanding who is lo… https://t.co/ercNIcqevBFollow us on Twitter
Work with us
We look for talented and passionate individuals as everyone at the Health Foundation has an important role to play.View current vacancies
The Q community
Q is an initiative connecting people with improvement expertise across the UK.Find out more